title: [Avastin treatment in intraocular tumors].
abstract: Bevacizumab is used in the treatment of cancer where it inhibits tumor growth by blocking the formation of new blood vessels (blocking angiogenesis). The purpose of this paper is to evaluate the short-term safety and effectiveness of Avastin injected into the eyeball in cases with intraocular tumors following-up the subjective and objective postoperative results.
authors.forename: Laura
authors.initials: L
authors.lastname: Macovei
authors.forename: Benone
authors.initials: B
authors.lastname: Carstocea
authors.forename: Simona
authors.initials: S
authors.lastname: Buliga
authors.forename: Beatrice
authors.initials: B
authors.lastname: Cerbulescu
mesh_terms: D000328:Adult; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005134:Eye Neoplasms / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D056965:Injections, Intraocular; D017075:Laser Coagulation; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab